Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 46 entries
Sorted by: Best Match Show Resources per page
What is 'continuity of care'?.

Journal of health services research & policy

Gulliford M, Naithani S, Morgan M.
PMID: 17018200
J Health Serv Res Policy. 2006 Oct;11(4):248-50. doi: 10.1258/135581906778476490.

Continuity of care is concerned with the quality of care over time. There are two important perspectives on this. Traditionally, continuity of care is idealized in the patient's experience of a 'continuous caring relationship' with an identified health care...

Cite
Gulliford M, Naithani S, Morgan M. What is 'continuity of care'?. J Health Serv Res Policy. 2006;11(4):248-50doi: 10.1258/135581906778476490.
Gulliford, M., Naithani, S., & Morgan, M. (2006). What is 'continuity of care'?. Journal of health services research & policy, 11(4), 248-50. https://doi.org/10.1258/135581906778476490
Gulliford, Martin, et al. "What is 'continuity of care'?." Journal of health services research & policy vol. 11,4 (2006): 248-50. doi: https://doi.org/10.1258/135581906778476490
Gulliford M, Naithani S, Morgan M. What is 'continuity of care'?. J Health Serv Res Policy. 2006 Oct;11(4):248-50. doi: 10.1258/135581906778476490. PMID: 17018200.
Copy Download .nbib Format: NLM
Hypokalaemia, drugs and the QT interval - a recipe for disaster.

Acute medicine

Gulliford SR, Mushahwar S.
PMID: 22041618
Acute Med. 2011;10(2):109-10.

No abstract available.

Cite
Gulliford SR, Mushahwar S. Hypokalaemia, drugs and the QT interval - a recipe for disaster. Acute Med. 2011;10(2):109-10
Gulliford, S. R., & Mushahwar, S. (2011). Hypokalaemia, drugs and the QT interval - a recipe for disaster. Acute medicine, 10(2), 109-10.
Gulliford, Stephen R, and Mushahwar, Shukri. "Hypokalaemia, drugs and the QT interval - a recipe for disaster." Acute medicine vol. 10,2 (2011): 109-10.
Gulliford SR, Mushahwar S. Hypokalaemia, drugs and the QT interval - a recipe for disaster. Acute Med. 2011;10(2):109-10. PMID: 22041618.
Copy Download .nbib Format: NLM
Cost-effectiveness of a universal strategy of brief dietary intervention for primary prevention in primary care: population-based cohort study and Markov model.

Cost effectiveness and resource allocation : C/E

Gulliford MC, Bhattarai N, Charlton J, Rudisill C.
PMID: 24485221
Cost Eff Resour Alloc. 2014 Feb 02;12(1):4. doi: 10.1186/1478-7547-12-4.

BACKGROUND: A healthy diet is associated with reduced risk of diabetes, cardiovascular disease and cancer. The study aimed to evaluate the cost-effectiveness of a universal strategy to promote healthy diet through brief intervention in primary care.METHODS: The research was...

Cite
Gulliford MC, Bhattarai N, Charlton J, et al. Cost-effectiveness of a universal strategy of brief dietary intervention for primary prevention in primary care: population-based cohort study and Markov model. Cost Eff Resour Alloc. 2014;12(1):4doi: 10.1186/1478-7547-12-4.
Gulliford, M. C., Bhattarai, N., Charlton, J., & Rudisill, C. (2014). Cost-effectiveness of a universal strategy of brief dietary intervention for primary prevention in primary care: population-based cohort study and Markov model. Cost effectiveness and resource allocation : C/E, 12(1), 4. https://doi.org/10.1186/1478-7547-12-4
Gulliford, Martin C, et al. "Cost-effectiveness of a universal strategy of brief dietary intervention for primary prevention in primary care: population-based cohort study and Markov model." Cost effectiveness and resource allocation : C/E vol. 12,1 (2014): 4. doi: https://doi.org/10.1186/1478-7547-12-4
Gulliford MC, Bhattarai N, Charlton J, Rudisill C. Cost-effectiveness of a universal strategy of brief dietary intervention for primary prevention in primary care: population-based cohort study and Markov model. Cost Eff Resour Alloc. 2014 Feb 02;12(1):4. doi: 10.1186/1478-7547-12-4. PMID: 24485221; PMCID: PMC4015683.
Copy Download .nbib Format: NLM
Body Mass Index and Incident Type 1 and Type 2 Diabetes in Children and Young Adults: A Retrospective Cohort Study.

Journal of the Endocrine Society

Abbasi A, Juszczyk D, van Jaarsveld CHM, Gulliford MC.
PMID: 29264507
J Endocr Soc. 2017 Apr 25;1(5):524-537. doi: 10.1210/js.2017-00044. eCollection 2017 May 01.

CONTEXT: Little is known about the association between obesity and temporal trends in the incidence of diabetes in children and young adults.OBJECTIVE: We examined the recent incidence of types 1 and 2 diabetes in relation to a high body...

Cite
Abbasi A, Juszczyk D, van Jaarsveld CHM, et al. Body Mass Index and Incident Type 1 and Type 2 Diabetes in Children and Young Adults: A Retrospective Cohort Study. J Endocr Soc. 2017;1(5):524-537doi: 10.1210/js.2017-00044.
Abbasi, A., Juszczyk, D., van Jaarsveld, C. H. M., & Gulliford, M. C. (2017). Body Mass Index and Incident Type 1 and Type 2 Diabetes in Children and Young Adults: A Retrospective Cohort Study. Journal of the Endocrine Society, 1(5), 524-537. https://doi.org/10.1210/js.2017-00044
Abbasi, Ali, et al. "Body Mass Index and Incident Type 1 and Type 2 Diabetes in Children and Young Adults: A Retrospective Cohort Study." Journal of the Endocrine Society vol. 1,5 (2017): 524-537. doi: https://doi.org/10.1210/js.2017-00044
Abbasi A, Juszczyk D, van Jaarsveld CHM, Gulliford MC. Body Mass Index and Incident Type 1 and Type 2 Diabetes in Children and Young Adults: A Retrospective Cohort Study. J Endocr Soc. 2017 Apr 25;1(5):524-537. doi: 10.1210/js.2017-00044. eCollection 2017 May 01. PMID: 29264507; PMCID: PMC5686575.
Copy Download .nbib Format: NLM
Social enterprises and public health improvement in England: a qualitative case study.

Public health

Garnett E, Baeza J, Trenholm S, Gulliford M, Green J.
PMID: 29940430
Public Health. 2018 Aug;161:99-105. doi: 10.1016/j.puhe.2018.04.019. Epub 2018 Jun 23.

OBJECTIVES: To explore the contribution of social enterprises to publicly commissioned public health improvement and assess the risks and benefits of their role.STUDY DESIGN: Qualitative case study of four south London boroughs.METHODS: Documentary research; in-depth interviews with 19 key...

Cite
Garnett E, Baeza J, Trenholm S, et al. Social enterprises and public health improvement in England: a qualitative case study. Public Health. 2018;161:99-105doi: 10.1016/j.puhe.2018.04.019.
Garnett, E., Baeza, J., Trenholm, S., Gulliford, M., & Green, J. (2018). Social enterprises and public health improvement in England: a qualitative case study. Public health, 16199-105. https://doi.org/10.1016/j.puhe.2018.04.019
Garnett, Emma, et al. "Social enterprises and public health improvement in England: a qualitative case study." Public health vol. 161 (2018): 99-105. doi: https://doi.org/10.1016/j.puhe.2018.04.019
Garnett E, Baeza J, Trenholm S, Gulliford M, Green J. Social enterprises and public health improvement in England: a qualitative case study. Public Health. 2018 Aug;161:99-105. doi: 10.1016/j.puhe.2018.04.019. Epub 2018 Jun 23. PMID: 29940430.
Copy Download .nbib Format: NLM
Inequalities in developing multimorbidity over time: A population-based cohort study from an urban, multi-ethnic borough in the United Kingdom.

The Lancet regional health. Europe

Bisquera A, Turner EB, Ledwaba-Chapman L, Dunbar-Rees R, Hafezparast N, Gulliford M, Durbaba S, Soley-Bori M, Fox-Rushby J, Dodhia H, Ashworth M, Wang Y.
PMID: 34901910
Lancet Reg Health Eur. 2021 Nov 04;12:100247. doi: 10.1016/j.lanepe.2021.100247. eCollection 2022 Jan.

BACKGROUND: Social and material deprivation accelerate the development of multimorbidity, yet the mechanisms which drive multimorbidity pathways and trajectories remain unclear. We aimed to examine the association between health inequality, risk factors and accumulation or resolution of LTCs, taking...

Cite
Bisquera A, Turner EB, Ledwaba-Chapman L, et al. Inequalities in developing multimorbidity over time: A population-based cohort study from an urban, multi-ethnic borough in the United Kingdom. Lancet Reg Health Eur. 2021;12:100247doi: 10.1016/j.lanepe.2021.100247.
Bisquera, A., Turner, E. B., Ledwaba-Chapman, L., Dunbar-Rees, R., Hafezparast, N., Gulliford, M., Durbaba, S., Soley-Bori, M., Fox-Rushby, J., Dodhia, H., Ashworth, M., & Wang, Y. (2022). Inequalities in developing multimorbidity over time: A population-based cohort study from an urban, multi-ethnic borough in the United Kingdom. The Lancet regional health. Europe, 12100247. https://doi.org/10.1016/j.lanepe.2021.100247
Bisquera, Alessandra, et al. "Inequalities in developing multimorbidity over time: A population-based cohort study from an urban, multi-ethnic borough in the United Kingdom." The Lancet regional health. Europe vol. 12 (2022): 100247. doi: https://doi.org/10.1016/j.lanepe.2021.100247
Bisquera A, Turner EB, Ledwaba-Chapman L, Dunbar-Rees R, Hafezparast N, Gulliford M, Durbaba S, Soley-Bori M, Fox-Rushby J, Dodhia H, Ashworth M, Wang Y. Inequalities in developing multimorbidity over time: A population-based cohort study from an urban, multi-ethnic borough in the United Kingdom. Lancet Reg Health Eur. 2021 Nov 04;12:100247. doi: 10.1016/j.lanepe.2021.100247. eCollection 2022 Jan. PMID: 34901910; PMCID: PMC8640725.
Copy Download .nbib Format: NLM
Antihypertensive medications and COVID-19 diagnosis and mortality: Population-based case-control analysis in the United Kingdom.

British journal of clinical pharmacology

Rezel-Potts E, Douiri A, Chowienczyk PJ, Gulliford MC.
PMID: 33908074
Br J Clin Pharmacol. 2021 Dec;87(12):4598-4607. doi: 10.1111/bcp.14873. Epub 2021 May 10.

AIMS: Antihypertensive drugs have been implicated in coronavirus disease 2019 (COVID-19) susceptibility and severity, but estimated associations may be susceptible to bias. We aimed to evaluate antihypertensive medications and COVID-19 diagnosis and mortality, accounting for healthcare-seeking behaviour.METHODS: A population-based...

Cite
Rezel-Potts E, Douiri A, Chowienczyk PJ, et al. Antihypertensive medications and COVID-19 diagnosis and mortality: Population-based case-control analysis in the United Kingdom. Br J Clin Pharmacol. 2021;87(12):4598-4607doi: 10.1111/bcp.14873.
Rezel-Potts, E., Douiri, A., Chowienczyk, P. J., & Gulliford, M. C. (2021). Antihypertensive medications and COVID-19 diagnosis and mortality: Population-based case-control analysis in the United Kingdom. British journal of clinical pharmacology, 87(12), 4598-4607. https://doi.org/10.1111/bcp.14873
Rezel-Potts, Emma, et al. "Antihypertensive medications and COVID-19 diagnosis and mortality: Population-based case-control analysis in the United Kingdom." British journal of clinical pharmacology vol. 87,12 (2021): 4598-4607. doi: https://doi.org/10.1111/bcp.14873
Rezel-Potts E, Douiri A, Chowienczyk PJ, Gulliford MC. Antihypertensive medications and COVID-19 diagnosis and mortality: Population-based case-control analysis in the United Kingdom. Br J Clin Pharmacol. 2021 Dec;87(12):4598-4607. doi: 10.1111/bcp.14873. Epub 2021 May 10. PMID: 33908074; PMCID: PMC8239680.
Copy Download .nbib Format: NLM
Applying resolved and remission codes reduced prevalence of multimorbidity in an urban multi-ethnic population.

Journal of clinical epidemiology

Ledwaba-Chapman L, Bisquera A, Gulliford M, Dodhia H, Durbaba S, Ashworth M, Wang Y.
PMID: 34517101
J Clin Epidemiol. 2021 Dec;140:135-148. doi: 10.1016/j.jclinepi.2021.09.005. Epub 2021 Sep 11.

OBJECTIVE: To estimate the prevalence and determinants of multimorbidity in an urban, multi-ethnic area over 15-years and investigate the effect of applying resolved/remission codes on prevalence estimates.STUDY DESIGN AND SETTING: This is a population-based retrospective cross-sectional study using electronic...

Cite
Ledwaba-Chapman L, Bisquera A, Gulliford M, et al. Applying resolved and remission codes reduced prevalence of multimorbidity in an urban multi-ethnic population. J Clin Epidemiol. 2021;140:135-148doi: 10.1016/j.jclinepi.2021.09.005.
Ledwaba-Chapman, L., Bisquera, A., Gulliford, M., Dodhia, H., Durbaba, S., Ashworth, M., & Wang, Y. (2021). Applying resolved and remission codes reduced prevalence of multimorbidity in an urban multi-ethnic population. Journal of clinical epidemiology, 140135-148. https://doi.org/10.1016/j.jclinepi.2021.09.005
Ledwaba-Chapman, Lesedi, et al. "Applying resolved and remission codes reduced prevalence of multimorbidity in an urban multi-ethnic population." Journal of clinical epidemiology vol. 140 (2021): 135-148. doi: https://doi.org/10.1016/j.jclinepi.2021.09.005
Ledwaba-Chapman L, Bisquera A, Gulliford M, Dodhia H, Durbaba S, Ashworth M, Wang Y. Applying resolved and remission codes reduced prevalence of multimorbidity in an urban multi-ethnic population. J Clin Epidemiol. 2021 Dec;140:135-148. doi: 10.1016/j.jclinepi.2021.09.005. Epub 2021 Sep 11. PMID: 34517101.
Copy Download .nbib Format: NLM
Increased Dose to Organs in Urinary Tract Associates With Measures of Genitourinary Toxicity in Pooled Voxel-Based Analysis of 3 Randomized Phase III Trials.

Frontiers in oncology

Marcello M, Denham JW, Kennedy A, Haworth A, Steigler A, Greer PB, Holloway LC, Dowling JA, Jameson MG, Roach D, Joseph DJ, Gulliford SL, Dearnaley DP, Sydes MR, Hall E, Ebert MA.
PMID: 32793485
Front Oncol. 2020 Jul 22;10:1174. doi: 10.3389/fonc.2020.01174. eCollection 2020.

No abstract available.

Cite
Marcello M, Denham JW, Kennedy A, et al. Increased Dose to Organs in Urinary Tract Associates With Measures of Genitourinary Toxicity in Pooled Voxel-Based Analysis of 3 Randomized Phase III Trials. Front Oncol. 2020;10:1174doi: 10.3389/fonc.2020.01174.
Marcello, M., Denham, J. W., Kennedy, A., Haworth, A., Steigler, A., Greer, P. B., Holloway, L. C., Dowling, J. A., Jameson, M. G., Roach, D., Joseph, D. J., Gulliford, S. L., Dearnaley, D. P., Sydes, M. R., Hall, E., & Ebert, M. A. (2020). Increased Dose to Organs in Urinary Tract Associates With Measures of Genitourinary Toxicity in Pooled Voxel-Based Analysis of 3 Randomized Phase III Trials. Frontiers in oncology, 101174. https://doi.org/10.3389/fonc.2020.01174
Marcello, Marco, et al. "Increased Dose to Organs in Urinary Tract Associates With Measures of Genitourinary Toxicity in Pooled Voxel-Based Analysis of 3 Randomized Phase III Trials." Frontiers in oncology vol. 10 (2020): 1174. doi: https://doi.org/10.3389/fonc.2020.01174
Marcello M, Denham JW, Kennedy A, Haworth A, Steigler A, Greer PB, Holloway LC, Dowling JA, Jameson MG, Roach D, Joseph DJ, Gulliford SL, Dearnaley DP, Sydes MR, Hall E, Ebert MA. Increased Dose to Organs in Urinary Tract Associates With Measures of Genitourinary Toxicity in Pooled Voxel-Based Analysis of 3 Randomized Phase III Trials. Front Oncol. 2020 Jul 22;10:1174. doi: 10.3389/fonc.2020.01174. eCollection 2020. PMID: 32793485; PMCID: PMC7387667.
Copy Download .nbib Format: NLM
Impact of Pelvic Radiation Therapy for Prostate Cancer on Global Metabolic Profiles and Microbiota-Driven Gastrointestinal Late Side Effects: A Longitudinal Observational Study.

International journal of radiation oncology, biology, physics

Ferreira MR, Sands CJ, Li JV, Andreyev JN, Chekmeneva E, Gulliford S, Marchesi J, Lewis MR, Dearnaley DP.
PMID: 34352290
Int J Radiat Oncol Biol Phys. 2021 Dec 01;111(5):1204-1213. doi: 10.1016/j.ijrobp.2021.07.1713. Epub 2021 Aug 02.

PURPOSE: Radiation therapy to the prostate and pelvic lymph nodes (PLNRT) is part of the curative treatment of high-risk prostate cancer. Yet, the broader influence of radiation therapy on patient physiology is poorly understood. We conducted comprehensive global metabolomic...

Cite
Ferreira MR, Sands CJ, Li JV, et al. Impact of Pelvic Radiation Therapy for Prostate Cancer on Global Metabolic Profiles and Microbiota-Driven Gastrointestinal Late Side Effects: A Longitudinal Observational Study. Int J Radiat Oncol Biol Phys. 2021;111(5):1204-1213doi: 10.1016/j.ijrobp.2021.07.1713.
Ferreira, M. R., Sands, C. J., Li, J. V., Andreyev, J. N., Chekmeneva, E., Gulliford, S., Marchesi, J., Lewis, M. R., & Dearnaley, D. P. (2021). Impact of Pelvic Radiation Therapy for Prostate Cancer on Global Metabolic Profiles and Microbiota-Driven Gastrointestinal Late Side Effects: A Longitudinal Observational Study. International journal of radiation oncology, biology, physics, 111(5), 1204-1213. https://doi.org/10.1016/j.ijrobp.2021.07.1713
Ferreira, Miguel R, et al. "Impact of Pelvic Radiation Therapy for Prostate Cancer on Global Metabolic Profiles and Microbiota-Driven Gastrointestinal Late Side Effects: A Longitudinal Observational Study." International journal of radiation oncology, biology, physics vol. 111,5 (2021): 1204-1213. doi: https://doi.org/10.1016/j.ijrobp.2021.07.1713
Ferreira MR, Sands CJ, Li JV, Andreyev JN, Chekmeneva E, Gulliford S, Marchesi J, Lewis MR, Dearnaley DP. Impact of Pelvic Radiation Therapy for Prostate Cancer on Global Metabolic Profiles and Microbiota-Driven Gastrointestinal Late Side Effects: A Longitudinal Observational Study. Int J Radiat Oncol Biol Phys. 2021 Dec 01;111(5):1204-1213. doi: 10.1016/j.ijrobp.2021.07.1713. Epub 2021 Aug 02. PMID: 34352290; PMCID: PMC8609156.
Copy Download .nbib Format: NLM
Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy.

Journal of the National Cancer Institute

Kerns SL, Fachal L, Dorling L, Barnett GC, Baran A, Peterson DR, Hollenberg M, Hao K, Narzo AD, Ahsen ME, Pandey G, Bentzen SM, Janelsins M, Elliott RM, Pharoah PDP, Burnet NG, Dearnaley DP, Gulliford SL, Hall E, Sydes MR, Aguado-Barrera ME, Gómez-Caamaño A, Carballo AM, Peleteiro P, Lobato-Busto R, Stock R, Stone NN, Ostrer H, Usmani N, Singhal S, Tsuji H, Imai T, Saito S, Eeles R, DeRuyck K, Parliament M, Dunning AM, Vega A, Rosenstein BS, West CML.
PMID: 31095341
J Natl Cancer Inst. 2020 Feb 01;112(2):179-190. doi: 10.1093/jnci/djz075.

BACKGROUND: A total of 10%-20% of patients develop long-term toxicity following radiotherapy for prostate cancer. Identification of common genetic variants associated with susceptibility to radiotoxicity might improve risk prediction and inform functional mechanistic studies.METHODS: We conducted an individual patient...

Cite
Kerns SL, Fachal L, Dorling L, et al. Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy. J Natl Cancer Inst. 2020;112(2):179-190doi: 10.1093/jnci/djz075.
Kerns, S. L., Fachal, L., Dorling, L., Barnett, G. C., Baran, A., Peterson, D. R., Hollenberg, M., Hao, K., Narzo, A. D., Ahsen, M. E., Pandey, G., Bentzen, S. M., Janelsins, M., Elliott, R. M., Pharoah, P. D. P., Burnet, N. G., Dearnaley, D. P., Gulliford, S. L., Hall, E., Sydes, M. R., Aguado-Barrera, M. E., Gómez-Caamaño, A., Carballo, A. M., Peleteiro, P., Lobato-Busto, R., Stock, R., Stone, N. N., Ostrer, H., Usmani, N., Singhal, S., Tsuji, H., Imai, T., Saito, S., Eeles, R., DeRuyck, K., Parliament, M., Dunning, A. M., Vega, A., Rosenstein, B. S., & West, C. M. L. (2020). Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy. Journal of the National Cancer Institute, 112(2), 179-190. https://doi.org/10.1093/jnci/djz075
Kerns, Sarah L, et al. "Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy." Journal of the National Cancer Institute vol. 112,2 (2020): 179-190. doi: https://doi.org/10.1093/jnci/djz075
Kerns SL, Fachal L, Dorling L, Barnett GC, Baran A, Peterson DR, Hollenberg M, Hao K, Narzo AD, Ahsen ME, Pandey G, Bentzen SM, Janelsins M, Elliott RM, Pharoah PDP, Burnet NG, Dearnaley DP, Gulliford SL, Hall E, Sydes MR, Aguado-Barrera ME, Gómez-Caamaño A, Carballo AM, Peleteiro P, Lobato-Busto R, Stock R, Stone NN, Ostrer H, Usmani N, Singhal S, Tsuji H, Imai T, Saito S, Eeles R, DeRuyck K, Parliament M, Dunning AM, Vega A, Rosenstein BS, West CML. Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy. J Natl Cancer Inst. 2020 Feb 01;112(2):179-190. doi: 10.1093/jnci/djz075. PMID: 31095341; PMCID: PMC7019089.
Copy Download .nbib Format: NLM
Teaching Children with Autism to Tact the Private Events of Others.

Behavior analysis in practice

Belisle J, Dixon MR, Alholai A, Ellenberger L, Stanley C, Galliford M.
PMID: 32231977
Behav Anal Pract. 2019 Dec 11;13(1):169-173. doi: 10.1007/s40617-019-00334-9. eCollection 2020 Mar.

We evaluated the efficacy of a most-to-least intrusive error-correction/prompting procedure for teaching 3 children with autism to tact the private events of others through publicly accompanying stimuli. Participants did not reliably demonstrate correct tact responses to publicly observable stimuli...

Cite
Belisle J, Dixon MR, Alholai A, et al. Teaching Children with Autism to Tact the Private Events of Others. Behav Anal Pract. 2019;13(1):169-173doi: 10.1007/s40617-019-00334-9.
Belisle, J., Dixon, M. R., Alholai, A., Ellenberger, L., Stanley, C., & Galliford, M. (2020). Teaching Children with Autism to Tact the Private Events of Others. Behavior analysis in practice, 13(1), 169-173. https://doi.org/10.1007/s40617-019-00334-9
Belisle, Jordan, et al. "Teaching Children with Autism to Tact the Private Events of Others." Behavior analysis in practice vol. 13,1 (2020): 169-173. doi: https://doi.org/10.1007/s40617-019-00334-9
Belisle J, Dixon MR, Alholai A, Ellenberger L, Stanley C, Galliford M. Teaching Children with Autism to Tact the Private Events of Others. Behav Anal Pract. 2019 Dec 11;13(1):169-173. doi: 10.1007/s40617-019-00334-9. eCollection 2020 Mar. PMID: 32231977; PMCID: PMC7070128.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 46 entries